top of page
  • TikTok
treatments_banner.jpg

Home / Information / Treatments

Treatments

Be empowered with ALK+ lung cancer information you can rely on.

Patients diagnosed several years ago may have been treated with Crizotinib or Ceritinib.  Some patients may still be taking these drugs but most will have progressed to Alectinib, Brigatinib or Lorlatinib.  Patients diagnosed more recently, will probably have started on one of these three drugs.

Publications from the Charity

Name

Summary of Contents

Action

Glossary of terms

Some common abbreviations/terms used in thoracic oncology

Good Practice - What To Ask

This document is to empower patients to be involved in and better informed about their treatment.

Common Side Effects of Certain TKIs

This document summarises common side effects of certain TKIs reported by members of the ALK+ UK Group.

Gaining a second opinion

This document provides patients some advice on obtaining a second opinion.

Breaks In Treatment - NHS Rules

This document summarises the NHS rules that apply when a patient has an extended break in treatment.

Do Not Resuscitate Orders

This document summarises a guidance produced by the Charity's Medical and Scientific Panel.

Publications from Other Organisations

Name

Summary of Contents

Action

Blood Clots and ALK+

A repoprt on the incidence of blood clots in ALK+ patients.

Stereotactic Radiotherapy & Body Radiotherapy

An explanation of Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT).

Local Consolidated Treatment

This document is a summary of reports on the benefits of treating a small number of areas of progression with radiotherapy.

Brain Tumours

A booklet about bain mets, produced by the BrainsTrust charity.

Fertility and Reproduction

A report on fertility and reproduction concers.

Fertility and TKIs

A review of the effects 

Pleural Effusion

A short video.

Roy Castle - Targeted Therapies

This document is a very useful booklet produced by the Roy Castle Lung Cancer Foundation.

Colorado Cancer Centre Report

This document contains Dr Ross Camidge reporting on the median overall survival at his Colorado clinic.

Image
Image

ALK Positive Lung Cancer (UK) is committed to producing reliable, accurate and up-to-date content reflecting the best available research evidence and best clinical practice. We aim to provide unbiased information free from any commercial conflicts of interest.

ALK Positive Lung Cancer (UK) is a registered charity in England and Wales ((1181171) and Scotland (SC053692).  The registered office is at 1 Ethley Drive, Raglan, Monmouthshire, NP15 2FD.

The content of this website is for information only and should not be used for the diagnosis or treatment of medical conditions.  We are unable to offer specific medical advice and, if you are worried about any symptoms, you should consult your doctor.​​

No part of this publication may be reproduced or tansmitted in any form or by any means, electronically, mechanically or manually without permission in writing of ALK Positive Lung Cancer (UK).

Copyright © 2025 ALK Positive UK

bottom of page